Skip to main content

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency Cover

.blurhash-client-img { display: none !important; }

Efficacy and safety of dulaglutide in patients with absolute insulin deficiency

Endocrine Regulations

Volume 53 (2019): Issue 3 (July 2019)

By: Eiji Kutoh, Jyunka Hayashi and Alexandra N. Kuto

Open Access

|Aug 2019

Articles in this issue

DOI: https://doi.org/10.2478/enr-2019-0019 | Journal eISSN: 1336-0329 | Journal ISSN: 1210-0668

Journal RSS Feed

Language: English

Page range: 187 - 190

Published on: Aug 24, 2019

Published by: Slovak Academy of Sciences, Institute of Experimental Endocrinology

In partnership with: Paradigm Publishing Services

Publication frequency: 1 issue per year

Keywords:

type 1 diabetes,

insulin deficiency

Related subjects:

Molecular biology,

Basic medical science,

Basic medical science, other,

Clinical medicine,

Internal medicine,

Endocrinology, diabetology

© 2019 Eiji Kutoh, Jyunka Hayashi, Alexandra N. Kuto, published by Slovak Academy of Sciences, Institute of Experimental Endocrinology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Volume 53 (2019): Issue 3 (July 2019)

Previous article